These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 22445477)

  • 1. Vancomycin levels are frequently subtherapeutic during continuous venovenous hemodialysis (CVVHD).
    Wilson FP; Berns JS
    Clin Nephrol; 2012 Apr; 77(4):329-31. PubMed ID: 22445477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vancomycin dosing and monitoring for patients with end-stage renal disease receiving intermittent hemodialysis.
    Crew P; Heintz SJ; Heintz BH
    Am J Health Syst Pharm; 2015 Nov; 72(21):1856-64. PubMed ID: 26490819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vancomycin: the need to suit serum concentrations in hemodialysis patients.
    Marengo LL; Del Fiol Fde S; Oliveira Sde J; Nakagawa C; Croco EL; Barberato-Filho S; Peçanha MP; Silva DF; Toledo MI
    Braz J Infect Dis; 2010; 14(2):203-8. PubMed ID: 20563453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin dosing in patients on intermittent hemodialysis.
    Vandecasteele SJ; De Vriese AS
    Semin Dial; 2011; 24(1):50-5. PubMed ID: 21338394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of weight-based vancomycin dosing for hospitalized hemodialysis patients.
    Maxson R; Pate J; Starr J
    Ren Fail; 2016 Nov; 38(10):1677-1682. PubMed ID: 27756193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of vancomycin clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis.
    Joy MS; Matzke GR; Frye RF; Palevsky PM
    Am J Kidney Dis; 1998 Jun; 31(6):1019-27. PubMed ID: 9631848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum vancomycin levels resulting from continuous or intermittent infusion in critically ill burn patients with or without continuous renal replacement therapy.
    Akers KS; Cota JM; Chung KK; Renz EM; Mende K; Murray CK
    J Burn Care Res; 2012; 33(6):e254-62. PubMed ID: 22878490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerated Venovenous Hemofiltration as a Transitional Renal Replacement Therapy in the Intensive Care Unit.
    Allegretti AS; Endres P; Parris T; Zhao S; May M; Sylvia-Reardon M; Bezreh N; Culbert-Costley R; Ananian L; Roberts RJ; Lopez N; Charytan DM; Tolkoff-Rubin N
    Am J Nephrol; 2020; 51(4):318-326. PubMed ID: 32097936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inadequate antibiotic dosing in patients receiving sustained low efficiency dialysis.
    Keough LA; Krauss A; Hudson JQ
    Int J Clin Pharm; 2018 Oct; 40(5):1250-1256. PubMed ID: 30051232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vancomycin levels are frequently subtherapeutic in critically ill patients: a prospective observational study.
    Bakke V; Sporsem H; Von der Lippe E; Nordøy I; Lao Y; Nyrerød HC; Sandvik L; Hårvig KR; Bugge JF; Helset E
    Acta Anaesthesiol Scand; 2017 Jul; 61(6):627-635. PubMed ID: 28444760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystatin C-Guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project.
    Frazee E; Rule AD; Lieske JC; Kashani KB; Barreto JN; Virk A; Kuper PJ; Dierkhising RA; Leung N
    Am J Kidney Dis; 2017 May; 69(5):658-666. PubMed ID: 28131530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Observational clinical study on the effects of different dosing regimens on vancomycin target levels in critically ill patients: Continuous versus intermittent application.
    Tafelski S; Nachtigall I; Troeger U; Deja M; Krannich A; Günzel K; Spies C;
    J Infect Public Health; 2015; 8(4):355-63. PubMed ID: 25794497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and total elimination of meropenem and vancomycin in intensive care unit patients undergoing extended daily dialysis.
    Kielstein JT; Czock D; Schöpke T; Hafer C; Bode-Böger SM; Kuse E; Keller F; Fliser D
    Crit Care Med; 2006 Jan; 34(1):51-6. PubMed ID: 16374156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of vancomycin when administered during high flux hemodialysis.
    Foote EF; Dreitlein WB; Steward CA; Kapoian T; Walker JA; Sherman RA
    Clin Nephrol; 1998 Jul; 50(1):51-5. PubMed ID: 9710347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An update on vancomycin dosing and monitoring practices in hemodialysis patients.
    Zhang M; Dresser L; Battistella M
    CANNT J; 2013; 23(4):25-7; quiz 28-9. PubMed ID: 24660521
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of Continuous Infusion Vancomycin Administration in a Critically Ill Trauma Population.
    Bissell BD; Riggi G; Morrison C
    J Intensive Care Med; 2020 Jun; 35(6):570-575. PubMed ID: 29642744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vancomycin during the Last Hour of the Hemodialysis Session: A Pharmacokinetic Analysis.
    Ghouti-Terki L; Chasseuil E; Rabot N; Paintaud G; François M; Birmelé B; Darrouzain F; Büchler M; Halimi JM; Ternant D
    Nephron; 2017; 135(4):261-267. PubMed ID: 28152540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic drug monitoring of piperacillin-tazobactam using spent dialysate effluent in patients receiving continuous venovenous hemodialysis.
    Connor MJ; Salem C; Bauer SR; Hofmann CL; Groszek J; Butler R; Rehm SJ; Fissell WH
    Antimicrob Agents Chemother; 2011 Feb; 55(2):557-60. PubMed ID: 21115798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial vancomycin dosing protocol to achieve therapeutic serum concentrations in patients undergoing hemodialysis.
    Zelenitsky SA; Ariano RE; McCrae ML; Vercaigne LM
    Clin Infect Dis; 2012 Aug; 55(4):527-33. PubMed ID: 22573855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vancomycin dosing in patients undergoing maintenance hemodialysis.
    Rymarz A; Brodowska-Kania D; Gomółka M; Józefczak-Bergier E; Dzierżanowska M; Niemczyk S
    Int Urol Nephrol; 2014 Aug; 46(8):1681-2. PubMed ID: 24696106
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.